Technical Trend Overview and Price Movement
TTK Healthcare’s current price stands at ₹887.80, up from the previous close of ₹874.35, with intraday highs reaching ₹899.50 and lows of ₹864.85. The stock remains significantly below its 52-week high of ₹1,402.00, while comfortably above its 52-week low of ₹807.00. This price action suggests a consolidation phase after a period of volatility.
The technical trend has shifted from bearish to mildly bearish, indicating a slight easing of downward pressure but no definitive bullish reversal. This nuanced change is reflected in the daily moving averages, which remain mildly bearish, signalling that short-term momentum is still under pressure despite recent gains.
MACD and RSI: Divergent Signals
The Moving Average Convergence Divergence (MACD) indicator presents a mixed scenario. On a weekly basis, the MACD is mildly bullish, suggesting some positive momentum building in the near term. However, the monthly MACD remains bearish, indicating that the longer-term trend has yet to confirm a sustained recovery. This divergence between weekly and monthly MACD readings highlights the stock’s current technical uncertainty.
Meanwhile, the Relative Strength Index (RSI) shows no clear signal on both weekly and monthly charts. The absence of an RSI signal suggests that the stock is neither overbought nor oversold, reinforcing the idea of a sideways or consolidative price movement. Investors should watch for any RSI movement beyond the typical 30-70 range to identify potential breakout or breakdown points.
Bollinger Bands and KST Indicate Caution
Bollinger Bands on both weekly and monthly timeframes are mildly bearish, implying that price volatility is skewed towards the downside. This technical setup often precedes periods of price compression or potential declines, signalling that traders should remain cautious.
The Know Sure Thing (KST) indicator, a momentum oscillator, is bearish on both weekly and monthly charts. This reinforces the notion that the stock’s momentum remains weak over multiple time horizons, despite short-term fluctuations.
Crushing the market! This Small Cap from Aerospace & Defense just earned its spot in our Top 1% with impressive gains. Don't let this opportunity slip through your hands.
- - Recent Top 1% qualifier
- - Impressive market performance
- - Sector leader
On-Balance Volume and Dow Theory Insights
On-Balance Volume (OBV) analysis reveals no clear trend on the weekly chart, while the monthly OBV is mildly bearish. This suggests that volume flow is not strongly supporting price advances, a factor that often precedes weaker price rallies or potential reversals.
Dow Theory assessments align with the mildly bearish weekly trend, while the monthly Dow Theory shows no definitive trend. This mixed reading further emphasises the stock’s current technical indecision, with neither bulls nor bears firmly in control over the medium term.
Comparative Performance Against Sensex
TTK Healthcare’s returns relative to the Sensex over various periods paint a challenging picture. Over the past week, the stock gained 1.57%, slightly underperforming the Sensex’s 2.18% rise. However, over the last month, TTK Healthcare outperformed with a 9.28% return compared to the Sensex’s 5.35%.
Year-to-date, the stock has declined by 14.28%, significantly worse than the Sensex’s 7.86% fall. Over the last year, the underperformance is more pronounced, with TTK Healthcare down 28.48% versus a flat Sensex return. The three-year and ten-year returns also highlight the stock’s struggles, with losses of 32.58% and 8.21% respectively, contrasting sharply with the Sensex’s robust gains of 31.67% and 203.82% over the same periods.
On a more positive note, the five-year return of 74.08% surpasses the Sensex’s 64.59%, indicating that the stock has delivered value over a longer horizon despite recent setbacks.
Mojo Score and Rating Update
MarketsMOJO assigns TTK Healthcare a Mojo Score of 42.0, reflecting a cautious stance. The Mojo Grade was downgraded from Hold to Sell on 21 July 2025, signalling a deterioration in the stock’s technical and fundamental outlook. The micro-cap classification further underscores the stock’s higher risk profile, often associated with greater volatility and lower liquidity.
Considering TTK Healthcare Ltd.? Wait! SwitchER has found potentially better options in Diversified and beyond. Compare this micro-cap with top-rated alternatives now!
- - Better options discovered
- - Diversified + beyond scope
- - Top-rated alternatives ready
Investor Takeaway and Outlook
TTK Healthcare’s current technical profile suggests a cautious approach for investors. The mildly bearish trend, combined with mixed momentum indicators, points to a stock that is struggling to find clear directional strength. The divergence between weekly and monthly MACD readings, alongside neutral RSI signals, indicates that while short-term momentum may be improving, longer-term pressures persist.
Price remains well below the 52-week high, and volume indicators do not strongly support a sustained rally. The downgrade to a Sell rating by MarketsMOJO reflects these concerns, highlighting the need for investors to weigh risks carefully.
However, the stock’s outperformance over the past month and five-year horizon suggests that selective investors with a longer-term view may find value if the company can stabilise its fundamentals and technicals. Monitoring key support levels near ₹807 and resistance around ₹900 will be critical in the coming weeks.
In summary, TTK Healthcare Ltd. remains a micro-cap with mixed technical signals and a cautious outlook. Investors should remain vigilant and consider alternative opportunities within the diversified sector that may offer clearer momentum and stronger technical profiles.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
